Because the individual and combined expression patterns of PARP1, γH2AX, BRCA1, and BRCA2 were significantly associated with advanced clinicopathologic factors and survival of osteosarcoma patients, we evaluated the effects of PARP inhibition on the survival of osteosarcoma cells. This evidence concerns the gene BRCA2 and osteosarcoma.